The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
MicroRNA (miRNA)-Global Market Insights and Sales Trends 2025
Synopsis
The global MicroRNA (miRNA) market size is expected to reach US$ 382.1 million by 2029, growing at a CAGR of 10.5% from 2023 to 2029. The market is mainly driven by the significant applications of MicroRNA (miRNA) in various end use industries. The expanding demands from the Cancer, Infectious Diseases, Immunological Disorder and Cardiovascular Disease, are propelling MicroRNA (miRNA) market. Sample collection, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the miRNA cDNA Synthesis segment is estimated at % CAGR for the next seven-year period.
Asia Pacific shows high growth potential for MicroRNA (miRNA) market, driven by demand from China, the second largest economy with some signs of stabilising, the MicroRNA (miRNA) market in China is forecast to reach US$ million by 2029, trailing a CAGR of % over the 2023-2029 period, while the U.S. market will reach US$ million by 2029, exhibiting a CAGR of % during the same period.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for MicroRNA (miRNA), with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global MicroRNA (miRNA) market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global MicroRNA (miRNA) market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, MicroRNA (miRNA) sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of MicroRNA (miRNA) covered in this report include Thermofisher Scientific (Life Technologies), Agilent Technologies, Merck KGaA, QIAGEN (Exiqon), NanoString Technologies, Inc., Dharmacon (Horizon Discovery Group), Synlogic, GeneCopoeia, Inc. and New England Biolabs, etc.
The global MicroRNA (miRNA) market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Thermofisher Scientific (Life Technologies)
Agilent Technologies
Merck KGaA
QIAGEN (Exiqon)
NanoString Technologies, Inc.
Dharmacon (Horizon Discovery Group)
Synlogic
GeneCopoeia, Inc.
New England Biolabs
Quantabio
NanoString Technologies, Inc.
BioGenex
SeqMatic LLC
Global MicroRNA (miRNA) market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global MicroRNA (miRNA) market, Segment by Type:
Sample collection
miRNA cDNA Synthesis
Profiling & Purification
Detection
Functional Studies
Global MicroRNA (miRNA) market, by Application
Cancer
Infectious Diseases
Immunological Disorder
Cardiovascular Disease
Neurological Disease
Others
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of MicroRNA (miRNA) companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
The global MicroRNA (miRNA) market size is expected to reach US$ 382.1 million by 2029, growing at a CAGR of 10.5% from 2023 to 2029. The market is mainly driven by the significant applications of MicroRNA (miRNA) in various end use industries. The expanding demands from the Cancer, Infectious Diseases, Immunological Disorder and Cardiovascular Disease, are propelling MicroRNA (miRNA) market. Sample collection, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the miRNA cDNA Synthesis segment is estimated at % CAGR for the next seven-year period.
Asia Pacific shows high growth potential for MicroRNA (miRNA) market, driven by demand from China, the second largest economy with some signs of stabilising, the MicroRNA (miRNA) market in China is forecast to reach US$ million by 2029, trailing a CAGR of % over the 2023-2029 period, while the U.S. market will reach US$ million by 2029, exhibiting a CAGR of % during the same period.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for MicroRNA (miRNA), with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global MicroRNA (miRNA) market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global MicroRNA (miRNA) market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, MicroRNA (miRNA) sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of MicroRNA (miRNA) covered in this report include Thermofisher Scientific (Life Technologies), Agilent Technologies, Merck KGaA, QIAGEN (Exiqon), NanoString Technologies, Inc., Dharmacon (Horizon Discovery Group), Synlogic, GeneCopoeia, Inc. and New England Biolabs, etc.
The global MicroRNA (miRNA) market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Thermofisher Scientific (Life Technologies)
Agilent Technologies
Merck KGaA
QIAGEN (Exiqon)
NanoString Technologies, Inc.
Dharmacon (Horizon Discovery Group)
Synlogic
GeneCopoeia, Inc.
New England Biolabs
Quantabio
NanoString Technologies, Inc.
BioGenex
SeqMatic LLC
Global MicroRNA (miRNA) market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global MicroRNA (miRNA) market, Segment by Type:
Sample collection
miRNA cDNA Synthesis
Profiling & Purification
Detection
Functional Studies
Global MicroRNA (miRNA) market, by Application
Cancer
Infectious Diseases
Immunological Disorder
Cardiovascular Disease
Neurological Disease
Others
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of MicroRNA (miRNA) companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Index1 Market Overview of MicroRNA (miRNA)
1.1 MicroRNA (miRNA) Market Overview
1.1.1 MicroRNA (miRNA) Product Scope
1.1.2 MicroRNA (miRNA) Market Status and Outlook
1.2 Global MicroRNA (miRNA) Market Size Overview by Region 2018 VS 2022 VS 2029
1.3 Global MicroRNA (miRNA) Market Size by Region (2018-2029)
1.4 Global MicroRNA (miRNA) Historic Market Size by Region (2018-2023)
1.5 Global MicroRNA (miRNA) Market Size Forecast by Region (2024-2029)
1.6 Key Regions, MicroRNA (miRNA) Market Size (2018-2029)
1.6.1 North America MicroRNA (miRNA) Market Size (2018-2029)
1.6.2 Europe MicroRNA (miRNA) Market Size (2018-2029)
1.6.3 Asia-Pacific MicroRNA (miRNA) Market Size (2018-2029)
1.6.4 Latin America MicroRNA (miRNA) Market Size (2018-2029)
1.6.5 Middle East & Africa MicroRNA (miRNA) Market Size (2018-2029)
2 MicroRNA (miRNA) Market by Type
2.1 Introduction
2.1.1 Sample collection
2.1.2 miRNA cDNA Synthesis
2.1.3 Profiling & Purification
2.1.4 Detection
2.1.5 Functional Studies
2.2 Global MicroRNA (miRNA) Market Size by Type: 2018 VS 2022 VS 2029
2.2.1 Global MicroRNA (miRNA) Historic Market Size by Type (2018-2023)
2.2.2 Global MicroRNA (miRNA) Forecasted Market Size by Type (2024-2029)
2.3 Key Regions Market Size by Type
2.3.1 North America MicroRNA (miRNA) Revenue Breakdown by Type (2018-2029)
2.3.2 Europe MicroRNA (miRNA) Revenue Breakdown by Type (2018-2029)
2.3.3 Asia-Pacific MicroRNA (miRNA) Revenue Breakdown by Type (2018-2029)
2.3.4 Latin America MicroRNA (miRNA) Revenue Breakdown by Type (2018-2029)
2.3.5 Middle East and Africa MicroRNA (miRNA) Revenue Breakdown by Type (2018-2029)
3 MicroRNA (miRNA) Market Overview by Application
3.1 Introduction
3.1.1 Cancer
3.1.2 Infectious Diseases
3.1.3 Immunological Disorder
3.1.4 Cardiovascular Disease
3.1.5 Neurological Disease
3.1.6 Others
3.2 Global MicroRNA (miRNA) Market Size by Application: 2018 VS 2022 VS 2029
3.2.1 Global MicroRNA (miRNA) Historic Market Size by Application (2018-2023)
3.2.2 Global MicroRNA (miRNA) Forecasted Market Size by Application (2024-2029)
3.3 Key Regions Market Size by Application
3.3.1 North America MicroRNA (miRNA) Revenue Breakdown by Application (2018-2029)
3.3.2 Europe MicroRNA (miRNA) Revenue Breakdown by Application (2018-2029)
3.3.3 Asia-Pacific MicroRNA (miRNA) Revenue Breakdown by Application (2018-2029)
3.3.4 Latin America MicroRNA (miRNA) Revenue Breakdown by Application (2018-2029)
3.3.5 Middle East and Africa MicroRNA (miRNA) Revenue Breakdown by Application (2018-2029)
4 MicroRNA (miRNA) Competition Analysis by Players
4.1 Global MicroRNA (miRNA) Market Size by Players (2018-2023)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in MicroRNA (miRNA) as of 2022)
4.3 Date of Key Players Enter into MicroRNA (miRNA) Market
4.4 Global Top Players MicroRNA (miRNA) Headquarters and Area Served
4.5 Key Players MicroRNA (miRNA) Product Solution and Service
4.6 Competitive Status
4.6.1 MicroRNA (miRNA) Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 Thermofisher Scientific (Life Technologies)
5.1.1 Thermofisher Scientific (Life Technologies) Profile
5.1.2 Thermofisher Scientific (Life Technologies) Main Business
5.1.3 Thermofisher Scientific (Life Technologies) MicroRNA (miRNA) Products, Services and Solutions
5.1.4 Thermofisher Scientific (Life Technologies) MicroRNA (miRNA) Revenue (US$ Million) & (2018-2023)
5.1.5 Thermofisher Scientific (Life Technologies) Recent Developments
5.2 Agilent Technologies
5.2.1 Agilent Technologies Profile
5.2.2 Agilent Technologies Main Business
5.2.3 Agilent Technologies MicroRNA (miRNA) Products, Services and Solutions
5.2.4 Agilent Technologies MicroRNA (miRNA) Revenue (US$ Million) & (2018-2023)
5.2.5 Agilent Technologies Recent Developments
5.3 Merck KGaA
5.3.1 Merck KGaA Profile
5.3.2 Merck KGaA Main Business
5.3.3 Merck KGaA MicroRNA (miRNA) Products, Services and Solutions
5.3.4 Merck KGaA MicroRNA (miRNA) Revenue (US$ Million) & (2018-2023)
5.3.5 QIAGEN (Exiqon) Recent Developments
5.4 QIAGEN (Exiqon)
5.4.1 QIAGEN (Exiqon) Profile
5.4.2 QIAGEN (Exiqon) Main Business
5.4.3 QIAGEN (Exiqon) MicroRNA (miRNA) Products, Services and Solutions
5.4.4 QIAGEN (Exiqon) MicroRNA (miRNA) Revenue (US$ Million) & (2018-2023)
5.4.5 QIAGEN (Exiqon) Recent Developments
5.5 NanoString Technologies, Inc.
5.5.1 NanoString Technologies, Inc. Profile
5.5.2 NanoString Technologies, Inc. Main Business
5.5.3 NanoString Technologies, Inc. MicroRNA (miRNA) Products, Services and Solutions
5.5.4 NanoString Technologies, Inc. MicroRNA (miRNA) Revenue (US$ Million) & (2018-2023)
5.5.5 NanoString Technologies, Inc. Recent Developments
5.6 Dharmacon (Horizon Discovery Group)
5.6.1 Dharmacon (Horizon Discovery Group) Profile
5.6.2 Dharmacon (Horizon Discovery Group) Main Business
5.6.3 Dharmacon (Horizon Discovery Group) MicroRNA (miRNA) Products, Services and Solutions
5.6.4 Dharmacon (Horizon Discovery Group) MicroRNA (miRNA) Revenue (US$ Million) & (2018-2023)
5.6.5 Dharmacon (Horizon Discovery Group) Recent Developments
5.7 Synlogic
5.7.1 Synlogic Profile
5.7.2 Synlogic Main Business
5.7.3 Synlogic MicroRNA (miRNA) Products, Services and Solutions
5.7.4 Synlogic MicroRNA (miRNA) Revenue (US$ Million) & (2018-2023)
5.7.5 Synlogic Recent Developments
5.8 GeneCopoeia, Inc.
5.8.1 GeneCopoeia, Inc. Profile
5.8.2 GeneCopoeia, Inc. Main Business
5.8.3 GeneCopoeia, Inc. MicroRNA (miRNA) Products, Services and Solutions
5.8.4 GeneCopoeia, Inc. MicroRNA (miRNA) Revenue (US$ Million) & (2018-2023)
5.8.5 GeneCopoeia, Inc. Recent Developments
5.9 New England Biolabs
5.9.1 New England Biolabs Profile
5.9.2 New England Biolabs Main Business
5.9.3 New England Biolabs MicroRNA (miRNA) Products, Services and Solutions
5.9.4 New England Biolabs MicroRNA (miRNA) Revenue (US$ Million) & (2018-2023)
5.9.5 New England Biolabs Recent Developments
5.10 Quantabio
5.10.1 Quantabio Profile
5.10.2 Quantabio Main Business
5.10.3 Quantabio MicroRNA (miRNA) Products, Services and Solutions
5.10.4 Quantabio MicroRNA (miRNA) Revenue (US$ Million) & (2018-2023)
5.10.5 Quantabio Recent Developments
5.11 NanoString Technologies, Inc.
5.11.1 NanoString Technologies, Inc. Profile
5.11.2 NanoString Technologies, Inc. Main Business
5.11.3 NanoString Technologies, Inc. MicroRNA (miRNA) Products, Services and Solutions
5.11.4 NanoString Technologies, Inc. MicroRNA (miRNA) Revenue (US$ Million) & (2018-2023)
5.11.5 NanoString Technologies, Inc. Recent Developments
5.12 BioGenex
5.12.1 BioGenex Profile
5.12.2 BioGenex Main Business
5.12.3 BioGenex MicroRNA (miRNA) Products, Services and Solutions
5.12.4 BioGenex MicroRNA (miRNA) Revenue (US$ Million) & (2018-2023)
5.12.5 BioGenex Recent Developments
5.13 SeqMatic LLC
5.13.1 SeqMatic LLC Profile
5.13.2 SeqMatic LLC Main Business
5.13.3 SeqMatic LLC MicroRNA (miRNA) Products, Services and Solutions
5.13.4 SeqMatic LLC MicroRNA (miRNA) Revenue (US$ Million) & (2018-2023)
5.13.5 SeqMatic LLC Recent Developments
6 North America
6.1 North America MicroRNA (miRNA) Market Size by Country (2018-2029)
6.2 U.S.
6.3 Canada
7 Europe
7.1 Europe MicroRNA (miRNA) Market Size by Country (2018-2029)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific MicroRNA (miRNA) Market Size by Region (2018-2029)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America MicroRNA (miRNA) Market Size by Country (2018-2029)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa MicroRNA (miRNA) Market Size by Country (2018-2029)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 MicroRNA (miRNA) Market Dynamics
11.1 MicroRNA (miRNA) Industry Trends
11.2 MicroRNA (miRNA) Market Drivers
11.3 MicroRNA (miRNA) Market Challenges
11.4 MicroRNA (miRNA) Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
